Skip to content

Cerus CERS Total Revenue

Total Revenue at other companies

Haemonetics logo
HaemoneticsHAE
$346.35M+4.8%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$619.8M-10.5%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$592.1M+1.1%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$56.37M+99.0%
ADMA Biologics logo
ADMA BiologicsADMA
$114.49M-0.3%

Other financials

Income statement

See full
Operating income-$354.0K+94.0%
Net income-$1.6M+78.7%
EPS (diluted)-$0.01+75.0%

Balance sheet

See full
Cash & equivalents$27.9M+43.0%
Total debt$45.0M-43.3%
Total equity$67.6M+21.7%
Total assets$222.9M+7.8%

Cash flow

See full
Operating cash flow-$3.0M-261%
CapEx$233.0K+108%
Free cash flow-$3.3M-243%

Valuation

See full
Market cap$573.06M+124%
Enterprise value$590.17M+86.7%
P/S2.9×-1.0×

Profitability

See full
Gross margin64%
Operating margin-6.2%-2.1pp
Net margin-9.8%-2.8pp
FCF margin3.5%+1.9pp

Returns & leverage

See full
Return on equity-15.5%-5.6pp
Debt / equity0.7×-0.8×
Current ratio1.6×-0.7×

Where this comes from

Reported directly by Cerus in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Cerus’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cerus's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cerus's total revenue?
Cerus (CERS) reported total revenue of $53.66M in Q1 2026.
How has Cerus's total revenue changed year-over-year?
Cerus's total revenue increased by 24.1% year-over-year, from $43.24M to $53.66M.
What is the long-term trend for Cerus's total revenue?
Over 3 years (2021 to 2024), Cerus's total revenue has grown at a 8.1% compound annual growth rate (CAGR), from $159.52M to $201.32M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.